Many Patients With Metastatic Colon Cancer Miss Out On Recommended Biomarker Testing, Analysis Indicates
December 19, 2019
Cancer Network (12/18, Slater) reports a study indicates 40 percent of patients with metastatic colon cancer do not receive biomarker testing as recommended by ASCO and the National Comprehensive Cancer Network. The review study involved nearly 1,500 pati...